RELT anticorps (AA 35-366)
Aperçu rapide pour RELT anticorps (AA 35-366) (ABIN1886395)
Antigène
Voir toutes RELT AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 35-366
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 35 and 366 of Human RELT
-
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.100-1.250
Immunofluorescence: 1.100-1.200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- RELT (RELT Tumor Necrosis Factor Receptor (RELT))
-
Autre désignation
- TNFRSF19L
-
Sujet
-
The protein encoded by this gene is a member of the TNF-receptor superfamily.This receptor is especially abundant in hematologic tissues.It has been shown to activate the NF-kappaB pathway and selectively bind TNF receptor-associated factor 1 (TRAF1).This receptor is capable of stimulating T-cell proliferation in the presence of CD3 signaling, which suggests its regulatory role in immune response.Two alternatively spliced transcript variants of this gene encoding the same protein have been reported.[provided by RefSeq]
-
Poids moléculaire
- 46 kDa
-
ID gène
- 84957
-
NCBI Accession
- NP_116260, NM_032871
Antigène
-